EyePoint Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
WATERTOWN, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced that George Elston, Executive Vice President and Chief Financial Officer of EyePoint Pharmaceuticals, will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Wednesday, February 7, 2024 at 12:30 p.m. ET.
Related news for (EYPT)
- Breaking News: MoBot’s Latest Update as of 05/28/25 12:00 PM
- eyepoint pharmaceuticals announces closing of upsized public offering and full exercise of option to purchase additional shares
- eyepoint pharmaceuticals announces pricing of upsized public offering
- eyepoint pharmaceuticals announces proposed public offering of common stock
- 24/7 Market News Snapshot 28 October, 2024 – EyePoint Pharmaceuticals, Inc. Common Stock (NASDAQ:EYPT)
